Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J

As the third quarter of 2019 comes to an end, most biopharma companies are reporting their earnings as they head into the final lap for the year. Here’s a look at some of the bigger companies’ reports that came out this week.